🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
This study will enroll individuals who have: * Completed primary series of...
Status
Completed
Location
University of California, San Diego
Start Date
2021-12-06
Trial ID
NCT05077254
Aim: To investigate if a subcutaneous (s.c.) booster dose of 90 µg of the n...
Status
Unknown
Location
University Medical Center Groningen
Start Date
2022-04-21
Trial ID
NCT05124483
Treatments Being Tested
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
This phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnat...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07390968
For Phase 1 only. Additional information will be provided when Phase 2 is i...
Status
Unknown
Location
Center for Vaccine Development-Mali
Start Date
2022-06-02
Trial ID
NCT05490108
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
The SARS-CoV-2 virus causes severe respiratory illness and is an ongoing gl...
Status
Unknown
Location
Soroka UMC
Start Date
2022-01-06
Trial ID
NCT05516459
Treatments Being Tested
The scope of this Phase I/II study is to determine whether GLB-COV2-043 is ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-02-21
Trial ID
NCT05602961
Treatments Being Tested